Executive summary

Low body mass index, anemia, tobacco smoking, and coinfection are associated with postoperative complications in patients with tuberculosis destroyed lung, according to the results of a recent Chinese study published in BMC Pulmonary Medicine.

Treatment Action Group (TAG) launches newly available TB chapters of its 2021 Pipeline Report.

In 1921, the Bacillus Calmette-Guérin (BCG) tuberculosis vaccine was first administered to a human. The vaccine was developed by French scientists Albert Calmette and Camille Guérin to protect against tuberculosis of the lungs, a leading cause of death in the early 1900s.

An article published in Public Health Action features testimonials from 14 TB survivors in 12 countries regarding their experiences with hearing loss from injectable-containing treatment regimens for drug-resistant TB.

Advocates urge the Indian government to issue compulsory licenses for patents on bedaquiline and delamanid to make the drugs more affordable and accessible.

Civil society networks in India call for the Ministry of Health and Family Welfare and the National TB Elimination Program to take urgent action.

The Global Forum on TB Vaccines was held virtually on 20-22 April 2021, marking its 20th anniversary. The Global Forum on TB Vaccines is the world's largest gathering of stakeholders striving to develop new vaccines to prevent TB.

The winners of this year’s Kochon Awards and the Stop TB Affected Community and Civil Society Awards were announced during the Stop TB Partnership 34th Board Meeting held virtually on 28-30 September 2021.

The World Health Organization (WHO) Global TB Program launched a call for case studies and best practices on the adaptation and implementation of the WHO Multisectoral Accountability Framework on TB (MAF-TB).